EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Implementing systematic melanoma risk assessment and risk‐tailored surveillance in a skin cancer focussed dermatology clinic: A qualitative study of feasibility and acceptability to patients and clinic staff

A L Smith, A K Smit iD, B I Laginha, N Singh, B Gallo, L Martin, A E Cust iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.6976 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von A L Smith und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Melanoma, Dermatology, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC, Sydney Catalyst Translational Cancer Research Centre, University of New South Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

International bodies recommend that melanoma risk assessment should be integrated into skin cancer care provision, but evidence to support implementation is lacking.

Aim

To explore the acceptability and feasibility of implementing personalised melanoma risk assessment and tailored patient education and skin surveillance within routine clinical care.

Methods

This prospective qualitative implementation study was informed by the Theoretical Framework of Acceptability (TFA). Personalised, systematic melanoma risk assessment was implemented in the dermatology clinic at the Melanoma Institute Australia, Sydney, Australia February–May 2021. Pre‐ and post‐implementation observations and semi‐structured interviews with patients and staff were conducted (September 2020–March 2021). Observational notes and interview transcript data were analysed thematically using the TFA as a classifying framework.

Results

A total of 37 h of observations were made, and 29 patients and 12 clinic staff were interviewed. We found that the delivery of personalised melanoma risk estimates did not impact on patient flow through the clinic. Dermatologists reported that the personalised risk information enhanced their confidence in assessing patient risk and recommending tailored surveillance schedules. Most patients reported that the risk assessment and tailored information were a beneficial addition to their care. Among patients whose risk deviated from their expectations, some reported feeling worried, confused or mistrust in the risk information, including those at lower risk who were recommended to decrease surveillance frequency.

Conclusions

It is feasible and acceptable to patients and clinic staff to calculate and deliver personalised melanoma risk information and tailored surveillance as part of routine clinical care within dermatology clinics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaDermatologySkin NeoplasmsHumansFeasibility StudiesProspective StudiesRisk Assessment

Stichwörter der Autor:innen

early detectionimplementation sciencemelanomarisk assessmentscreeningskin cancersurveillance

Autor:innen und Institutionen

  • The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
  • Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

ORCID-Profile: A K Smit, A E Cust

Förderung

  • NHMRC
  • Sydney Catalyst Translational Cancer Research Centre
  • University of New South Wales
  • National Health and Medical Research Council

Zitieren

APA

Smith, A. L., Smit, A. K., Laginha, B. I., Singh, N., Gallo, B., Martin, L., & Cust, A. E. (2024). Implementing systematic melanoma risk assessment and risk‐tailored surveillance in a skin cancer focussed dermatology clinic: A qualitative study of feasibility and acceptability to patients and clinic staff. Cancer Medicine. https://doi.org/10.1002/cam4.6976

Vancouver

Smith AL, Smit AK, Laginha BI, Singh N, Gallo B, Martin L, et al. Implementing systematic melanoma risk assessment and risk‐tailored surveillance in a skin cancer focussed dermatology clinic: A qualitative study of feasibility and acceptability to patients and clinic staff. Cancer Medicine. 2024. doi:10.1002/cam4.6976

BibTeX
@article{Smith2024,
  author = {Smith, A L and Smit, A K and Laginha, B I and Singh, N and Gallo, B and Martin, L and Cust, A E},
  title = {Implementing systematic melanoma risk assessment and risk‐tailored surveillance in a skin cancer focussed dermatology clinic: A qualitative study of feasibility and acceptability to patients and clinic staff},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6976}
}
Kostenlos starten →